REVAMP 

Randomized controlled trial of the effect of intravenous iron on anemia in Malawian pregnant women

Start and End dates: 2017 to 2022

Source of Funding: Bill & Melinda Gates Foundation ($1.6 million)

An individual-randomized Phase III, open-label clinical trial assessing the effectiveness and safety of intravenous iron, ferric carboxymaltose versus oral iron pills in the prevention of anaemia in pregnant Malawian women in Blantyre and Zomba districts. We are recruiting 862 women during their second trimester and following them up until delivery and their infant until 1 year of age.